September 20, 2022
Shionogi said on September 16 that its group company has signed a sublicense deal with South Korea’s Ildong Pharmaceutical to pursue an emergency use authorization (EUA) for its COVID-19 pill ensitrelvir in the country and to subsequently negotiate for government...read more